CODX
Co-Diagnostics, Inc.NASDAQHealthcare$1.54-0.32%ClosedMarket Cap: $1.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.10
P/S
2.75
EV/EBITDA
0.30
DCF Value
$7.42
FCF Yield
-1741.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.3%
Operating Margin
-8058.8%
Net Margin
-7533.6%
ROE
-125.5%
ROA
-189.5%
ROIC
-221.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $263.9K | 46.0% | $-26.5M | $-25.7M | $-16.54 | — |
| FY 2025 | $622.5K | 64.3% | $-50.2M | $-46.9M | $-35.25 | — |
| Q3 2025 | $145.4K | 81.9% | $-7.0M | $-5.9M | $-4.66 | — |
| Q2 2025 | $162.9K | 80.3% | $-8.1M | $-7.7M | $-7.00 | — |
| Q1 2025 | $50.3K | 57.1% | $-8.6M | $-7.5M | $-7.05 | — |
| Q4 2024 | $149.3K | -70.8% | $-11.9M | $-11.0M | $-10.01 | — |
| FY 2024 | $3.9M | 74.5% | $-40.1M | $-37.6M | $-37.20 | — |
| Q3 2024 | $641.1K | 53.6% | $-10.2M | $-9.7M | $-9.54 | — |
| Q2 2024 | $2.7M | 92.0% | $-7.7M | $-7.6M | $-7.57 | — |
| Q1 2024 | $252.7K | 7.2% | $-10.3M | $-9.3M | $-9.36 | — |
| Q4 2023 | $3.6M | 16.5% | $-11.8M | $-14.7M | $-14.10 | — |
| FY 2023 | $6.8M | 38.6% | $-42.7M | $-35.3M | $-36.00 | — |